<DOC>
	<DOC>NCT01263834</DOC>
	<brief_summary>The purpose of this study is to evaluate the adjunctive effect of intratenon Bevacizumab on the result of trabeculectomy in primary term of intraocular pressure (IOP).</brief_summary>
	<brief_title>Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome</brief_title>
	<detailed_description>Prospective interventional clinical trial Single center, outcome assessor-masked, active control, randomized controlled trial</detailed_description>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>Primary open angle glaucoma with primary mmctrabeculectomy indication combined phacoemulsification with trabeculectomy no more than 6 month of cataract surgery before trabeculectomy revised trabeculectomy active uveitic glaucoma neovascular glaucoma par planar vitrectomy conjunctival surgery allergy to bevacizumab or mitomycin C ischemic heart disease cerebrovascular disease renal failure liver failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Trabeculectomy</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>intraocular pressure</keyword>
</DOC>